Torrent Pharmaceuticals said it issued non-convertible debentures (NCDs) worth Rs 195 crore on private placement basis on 24 April 2020.
The NCDs bear a coupon rate of 7.70% p.a. and hold tenure of three years. The debentures will mature on 24 April 2023, the company said in an exchange filing made after market hours on friday, 24 April 2020.
Shares of the drug maker rose 0.72% to end at Rs 2440 on Friday. It has risen 30.66% in the past one month, underperforming the Nifty Pharma index which has risen 39.70% in the same period.
Torrent Pharmaceuticals manufactures bulk drugs and pharmaceutical formulations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app